Ketone bodies are known to be generated from acetyl-CoA when a large amount of acyl-CoA remains unmetabolised following the TCA cycle
and the potential for unmeasured confounding factors such as reasons underlying the decision to initiate GLP-1 RA therapy that could have influenced RA outcomes, they wrote
This part of the study may be the most clinically informative
We can talk to you about what happened to you and let you know if you have a legal claim against the at-fault companies
For tirzepatide, the starting dose is typically 2.5 mg weekly, increasing to 5 mg after four weeks, then 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg
Biologically they are the same in terms of result just that they differ in terms of method of absorption